Newsroom

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced strategic leadership changes to accelerate its next phase of growth. Michael Kauffman, M.D., Ph.D., currently lead director of the Board, has been appointed as the president of development and will join the Company’s executive leadership team, while John Johnson, a board member since 2020, has been appointe...

LAKE CITY, S.C.--(BUSINESS WIRE)--ICE Recycling rebrands to Vaiire to reflect its expanded polymer solutions and materials services capabilities....

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 31,500 common shares of the Company (the "Options") with an effective grant date of December 15, 2025. The Options have an exercise price...

MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today announced that it granted an equity award on December 15, 2025, as a material inducement to the employment of the company's newly-hired Executive Vice President and Chief Financial Officer, Amy O’Keefe. As previously disclosed, in connection with the appointment of O’Keefe as Executive Vice President and Chief Financial Officer effective December 8, 2025, Sleep Number granted O’Keefe an employment inducement award consi...

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $400 million of shares of its common stock. All of the shares are being offered by Immunome. In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day...

SAN RAMON, Calif.--(BUSINESS WIRE)--Five9 (Nasdaq: FIVN), provider of the Intelligent CX Platform, today announced that it has been named to Foundry’s Computerworld 2026 Best Places to Work in IT list for the third consecutive year, recognizing the company as one of the top organizations that challenge their IT staff while providing great benefits and compensation. This year, Five9 achieved several notable placements, including: #12 Overall for Midsize Companies, up from #13 in 2025 #7 for Work...

HOUSTON--(BUSINESS WIRE)--Quinones & Associates, PLLC is pleased to announce that founder Letitia Quinones-Hollins has been recognized in The Best Lawyers in America guide, a listing of the nation’s top attorneys, for 2026. The respected legal guide for a third consecutive year selected Ms. Quinones-Hollins for expertise in general and white-collar criminal defense work. “This honor is especially rewarding in that it comes from the lawyers who do this kind of work every single day,” said Ms...

MALIBU, Calif.--(BUSINESS WIRE)--Amend Treatment has released findings from a new national study examining how Complex PTSD (CPTSD) manifests in high-functioning women ages 30–55. Despite appearing outwardly successful, many respondents reported severe, untreated trauma symptoms including insomnia, emotional exhaustion, dissociation, and chronic people-pleasing behaviors. The study, Women & CPTSD: The Invisible Load, combined nationwide survey data with social media discourse analysis to ex...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming February 2, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Bitdeer Technologies Group (“Bitdeer” or the “Company”) (NASDAQ: BTDR) securities between June 6, 2024 and November 10, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BITDEER TECHNOLOGIES GROUP (BTDR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PART...

韩国首尔--(BUSINESS WIRE)--(美国商业资讯)-- Align Partners Capital Management Inc. (“Align Partners”)自2023年起成为Coway Co., Ltd. (“Coway”)股东，通过其管理或提供咨询的基金持有该公司超过4%的流通股。Align Partners宣布，已向Coway董事会发出第二封公开股东信，呼吁采取措施解决公司长期估值偏低的问题，并提升股东价值。Align Partners要求Coway于2026年1月30日前，公布一份体现上述建议的修订版企业价值提升计划。 在信函中，Align Partners认为Coway于2025年2月推出的计划不足以解决Coway持续估值偏低的问题，并敦促董事会采取以下七项举措：(1)制定明确的中长期估值和净资产收益率目标，同时配套具体执行方案；(2)明确并强化目标资本结构政策；(3)结合目标资本结构政策和全新股息所得税分离制度，更新股东回报政策；(4)加强投资者关系信息披露工作；(5)推进董事会独立性改革；(6)采取措施解决控股股东和少数股东之间的利益冲突问题；(7...